Vaccine Development for Epidemic-Potential Viruses
Funds the advancement of existing vaccine candidates against one named epidemic-prone virus, from lab testing through to a first human safety trial.
European CommissionGrant
About
The European Commission funds Research and Innovation Actions that advance an existing vaccine candidate, rather than starting from scratch, all the way to early human trials. Applicants must target exactly one of the eight listed viruses, and the Commission balances awards across the different viruses rather than funding purely by rank.
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.